Balchem Corporation  

(Public, NASDAQ:BCPC)   Watch this stock  
Find more results for BCPC
47.75
+0.51 (1.08%)
May 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 47.15 - 48.31
52 week 28.25 - 48.31
Open 47.25
Vol / Avg. 121,480.00/65,015.00
Mkt cap 1.42B
P/E 36.23
Div/yield 0.22/0.46
EPS 1.32
Shares 29.66M
Beta 0.74
Inst. own 77%
Jul 29, 2013
Q2 2013 Balchem Corp Earnings Release Add to calendar
Jun 20, 2013
Balchem Corp Annual Shareholder Meeting - 11:00AM EDT - Add to calendar
May 3, 2013
Q1 2013 Balchem Corp Earnings Conference Call
May 3, 2013
Q1 2013 Balchem Corp Earnings Release
Feb 21, 2013
Q4 2012 Balchem Corp Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin 12.36% 12.89%
Operating margin 18.78% 19.26%
EBITD margin - 22.36%
Return on average assets 12.88% 13.69%
Return on average equity 14.69% 15.84%
Employees 376 -
Carbon Disclosure Rating - -

Address

52 Sunrise Park Road
NEW HAMPTON, NY 10958
United States - Map
+1-845-3265600 (Phone)
+1-845-3265742 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in three segments: Specialty Products, Food, Pharma & Nutrition and Animal Nutrition & Health. The Food, Pharma & Nutrition (FPN) segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients. The Company's Specialty Products segment operates in industry as ARC Specialty Products. Ethylene oxide, at the 100% level, is sold as a sterilant gas, primarily for use in the health care industry. The Company's Animal Nutrition & Health segment provides the animal nutrition and health markets with products derived from the Company's microencapsulation, chelation, and basic choline chloride technologies.

Officers and directors

Dino A. Rossi Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Francis J. Fitzpatrick CPA Chief Financial Officer, Treasurer, Assistant Secretary
Age: 51
Bio & Compensation  - Reuters
Richard A. Bendure Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
William A. Backus CPA Chief Accounting Officer, Assistant Treasurer
Age: 45
Bio & Compensation  - Reuters
David F. Ludwig Vice President, General Manager - Specialty Products
Age: 54
Bio & Compensation  - Reuters
Matthew D. Houston General Counsel, Secretary
Age: 48
Bio & Compensation  - Reuters
John Y. Televantos Ph.D. Lead Independent Director
Age: 59
Bio & Compensation  - Reuters
Paul D. Coombs Independent Director
Age: 57
Bio & Compensation  - Reuters
David B. Fischer Independent Director
Age: 50
Bio & Compensation  - Reuters
Edward L. McMillan Independent Director
Age: 66
Bio & Compensation  - Reuters